3576-75-8 Usage
Molecular structure
Contains a six-membered ring fused to a five-membered ring, with a nitrogen atom in the central position.
Phenyl groups
Has two phenyl groups attached to the 5th and 7th positions of the molecule.
Decane family
Is a derivative of the decane family, which is a group of hydrocarbons with ten carbon atoms.
Hydroxyl group
Contains a hydroxyl group (-OH), making it a type of alcohol.
Chemical properties
Likely to have specific chemical properties due to its unique structure, which may include reactivity with other compounds and potential use in chemical reactions.
Biological properties
May have potential biological properties, such as interactions with biological molecules or effects on living organisms.
Applications
Potential applications in pharmaceuticals or materials science, although further research is needed to explore these possibilities.
Research
Further research is required to fully understand the properties and potential uses of 1,3-Diazatricyclo3.3.1.13,7decan-6-ol, 5,7-diphenyl-.
Check Digit Verification of cas no
The CAS Registry Mumber 3576-75-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,5,7 and 6 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 3576-75:
(6*3)+(5*5)+(4*7)+(3*6)+(2*7)+(1*5)=108
108 % 10 = 8
So 3576-75-8 is a valid CAS Registry Number.
InChI:InChI=1/C20H22N2O/c23-18-19(16-7-3-1-4-8-16)11-21-13-20(18,14-22(12-19)15-21)17-9-5-2-6-10-17/h1-10,18,23H,11-15H2
3576-75-8Relevant academic research and scientific papers
Synthesis of novel diazabicycles and their antiprotozoal activities
Wolkinger, Volker,Weis, Robert,Belaj, Ferdinand,Kaiser, Marcel,Brun, Reto,Saf, Robert,Seebacher, Werner
body text, p. 1166 - 1172 (2010/03/04)
We describe the synthesis of new diaryl substituted diazabicyclo[3.2.1] octanes from diazepanes which were prepared by the reduction of diazepanones. The formation of the bicyclic system was optimized by microwave irradiation and the structures of the new compounds were established by single crystal structure analysis and NMR spectroscopy. All new compounds were tested for their potencies against Plasmodium falciparum K1 and Trypanosoma b. rhodesiense, the causative organisms of malaria tropica and the East African form of sleeping sickness. CSIRO 2009.
